首页/数据集/Kinetics and binding affinities of anti-PD-1 antibody to human PD-1 determined by BLI.

Kinetics and binding affinities of anti-PD-1 antibody to human PD-1 determined by BLI.

NIAID Data Ecosystem2026-03-13 收录

数据链接：

https://figshare.com/articles/dataset/Kinetics_and_binding_affinities_of_anti-PD-1_antibody_to_human_PD-1_determined_by_BLI_/17710736 数据链接链接失效反馈

官方服务：

资源简介：

Kinetics and binding affinities of anti-PD-1 antibody to human PD-1 determined by BLI.

应用场景：

创建时间：

2021-12-31

相关数据集

ICI-5

免疫检查点抑制剂

心肌炎

· Animal Model: ICI-associated myocarditis· Animal Age: 8-12 Weeks· Animal Strain: A/J mouse· Number:o ICI-5: 8 controls and 20 aPD-1· Experimental Conditions: Mice were i.p. injected with anti-PD-1 a

DataCite Commons2025-03-11 更新120

PDB: 5X8M, Durvalumab in complex with Programmed death-ligand 1 (PD-L1) , random seed 1 (312K, 39°C, 500 ns)

药物-靶点相互作用模拟

免疫检查点抑制剂

Molecular Dynamics Simulations (500 nanoseconds) of Durvalumab in complex with Programmed death-ligand 1 at 312K (39°C). Includes PDB files obtained every 50 ns.

DataCite Commons2024-10-24 更新70

Developing & Optimizing Acute Myeloid Leukemia Specific Therapeutic Antibodies [CRISPR Screen]. Developing & Optimizing Acute Myeloid Leukemia Specific Therapeutic Antibodies [CRISPR Screen]

抗体药物研发

CRISPRi功能基因组学

Following nearly five decades with few approved therapies for acute myeloid leukemia (AML), the last three years have brought stellar progress with the U.S. Food and Drug Administration approving a nu

NIAID Data Ecosystem50

table1_Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?.docx

免疫检查点抑制剂

PD-L1生物标志物

Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can

NIAID Data Ecosystem100

Predictors of Acute Kidney Injury in Patients Prescribed Immune Checkpoint Inhibitor Therapy and Their Association with Death: A Systematic Review and Meta-Analysis

免疫检查点抑制剂

急性肾损伤

Immune checkpoint inhibitors (ICIs) are a novel and promising anti-cancer therapy. We conducted this systematic review to precisely quantify the occurrence and development for actue kidney injury(AKI)

Taylor & Francis Group2025-12-04 更新60